BIOLINERX     Print Page  Close Window

SEC filings
F-3
BIOLINERX LTD. filed this Form F-3 on 07/16/2015
Entire Document
 
 

 
 
The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state or jurisdiction where the offer or sale is not permitted.
 
SUBJECT TO COMPLETION, DATED July 16, 2015
 
$75,000,000
 
AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES
ORDINARY SHARES
DEBT SECURITIES
WARRANTS TO PURCHASE AMERICAN DEPOSITARY SHARES
UNITS
______________________________
 
We may offer from time to time, in one or more series:
 
 
·
American Depositary Shares (“ADSs”);
 
 
·
ordinary shares;
 
 
·
debt securities;
 
 
·
warrants to purchase ADSs; and
 
 
·
units consisting of two or more of these classes or series of securities.
 
We may offer these securities in amounts, at prices and on terms determined at the time of offering. The specific plan of distribution for any securities to be offered will be provided in a prospectus supplement. If we use agents, underwriters or dealers to sell these securities, a prospectus supplement will name them and describe their compensation.
 
The specific terms of any securities to be offered will be described in a supplement to this prospectus. This prospectus may not be used to sell securities unless accompanied by a prospectus supplement. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and any prospectus supplement, together with additional information described under the heading “Where You Can Find More Information,” before you make an investment decision.
 
Our ADSs are quoted on the Nasdaq Capital Market under the symbol “BLRX.” On July 15, 2015, the closing price of our ADSs on the Nasdaq Capital Market was $2.32 per ADS.
 
Our ordinary shares currently trade on the Tel Aviv Stock Exchange, or TASE, under the symbol “BLRX.”  On July 15, 2015, the last reported sale price of our ordinary shares was NIS 8.65, or $2.30 per share (based on the exchange rate reported by the Bank of Israel on such date).
 
______________________________
 
Investing in our securities involves a high degree of risk.  See “Risk Factors” contained in the applicable prospectus supplement or the documents we incorporate by reference in this prospectus to read about factors you should consider before investing in our securities.